Varex Imaging (VREX) Stock Forecast & Price Target

Varex Imaging Corp has demonstrated strong financial performance, with the industrial segment achieving a record revenue of $76.8 million, reflecting a 25.3% year-over-year growth, while the medical segment also reported a solid increase of 5.3% year-over-year, generating $152.1 million. China is exhibiting signs of recovery, with management forecasting stronger order activity in the coming years, supported by initiatives in rural healthcare and stabilized pricing conditions in the CT tube market. Additionally, Varex Imaging is scaling operations in India and advancing its innovative photon counting CT technology, both of which are expected to contribute to sustained revenue growth and profitability as the company enhances its manufacturing capabilities and expands its customer base.

Varex Imaging Corp faces significant challenges that contribute to a negative outlook, primarily due to ongoing trade tensions between the U.S. and China, which may adversely affect approximately 15% of its revenues derived from that region. The company's cash and equivalents have decreased by $58 million year-over-year to $155 million, raising concerns about its liquidity in a challenging economic environment. Furthermore, the company's sales have been impacted by the Chinese government's anti-corruption actions and increased import costs, which complicates its operational efficiency and profitability.